Retrospective evaluation of risk factors for worsening renal function after angiotensin-converting enzyme inhibitor treatment in dogs
Journal of Veterinary Internal Medicine · 2025
DOI: 10.1111/jvim.17252 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Veterinary Internal Medicine, 2025. Verfasst von Yelim Lee und 7 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Veterinary Internal Medicine, College of Veterinary Medicine, Chungbuk National University, Cheongju, 28644, Republic of Korea. Hauptthemen laut MEDLINE: Angiotensin-Converting Enzyme Inhibitors, Dog Diseases, Creatinine. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Korea Institute of Planning and Evaluation for Technology in Food, Agriculture and Forestry, National Research Foundation of Korea.
Abstract (Originalsprache)
Background
Angiotensin-converting enzyme inhibitors (ACEi) have the potential to cause worsening renal function (WRF). Therefore, reevaluation of renal function is recommended 1-2 weeks after starting ACEi therapy.
Objectives
To identify risk factors for WRF in dogs receiving ACEi for cardiac diseases, proteinuria, or systemic hypertension. Animals A total of 156 client-owned dogs that received ACEi were included.
Methods
Serum creatinine concentration was determined at the initial presentation and first reevaluation to detect and grade WRF (increase in sCr ≥ 0.3 mg/dL). Grade 1 (nonazotemic), 2 (mild), and 3 (moderate to severe) WRF were characterized by sCr remaining ≤1.6 mg/dL, 1.7-2.5 mg/dL increase, and 2.6-5.0 mg/dL increase, respectively. Demographic and serum chemistry data, such as total protein, albumin, blood urea nitrogen, creatinine, symmetric dimethylarginine, glucose, triglyceride, total cholesterol concentrations, and serum electrolyte concentrations at first presentation, were evaluated. Multivariable modeling was performed to identify risk factors for WRF after treatment with ACEi.
Results
Worsening renal function was identified in 27/156 (17%, 95% confidence interval [CI], 0.11-0.23) dogs after ACEi treatment. It was classified as Grades 1, 2, and 3 in 17, 2, and 8 dogs, respectively. The only significant factors associated with WRF in dogs receiving ACEi were concurrent administration of furosemide (odds ratio, 5.05; 95% CI, 2.05-12.4; P < .001) and pre-existing azotemia (odds ratio, 3.21; 95% CI, 1.28-8.03; P = .01). Conclusions and Clinical Importance Although WRF is uncommon and mild, ACEi should be cautiously prescribed in dogs receiving furosemide or those with pre-existing azotemia.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Veterinary Internal Medicine, College of Veterinary Medicine, Chungbuk National University, Cheongju, 28644, Republic of Korea.
- Bundang Leaders Animal Medical Center, Seongnam, 13636, South Korea.
ORCID-Profile: Yelim Lee, Minju Baek, Dongseop Lee, Jinyeong Park, Yeon Chae, Byeong-Teck Kang, Taesik Yun, Hakhyun Kim
Förderung
- Korea Institute of Planning and Evaluation for Technology in Food, Agriculture and Forestry
- National Research Foundation of Korea
Zitieren
APA
Lee, Y., Baek, M., Lee, D., Park, J., Chae, Y., Kang, B. T., Yun, T., & Kim, H. (2025). Retrospective evaluation of risk factors for worsening renal function after angiotensin-converting enzyme inhibitor treatment in dogs. Journal of Veterinary Internal Medicine. https://doi.org/10.1111/jvim.17252
Vancouver
Lee Y, Baek M, Lee D, Park J, Chae Y, Kang BT, et al. Retrospective evaluation of risk factors for worsening renal function after angiotensin-converting enzyme inhibitor treatment in dogs. Journal of Veterinary Internal Medicine. 2025. doi:10.1111/jvim.17252
BibTeX
@article{Lee2025,
author = {Lee, Yelim and Baek, Minju and Lee, Dongseop and Park, Jinyeong and Chae, Yeon and Kang, Byeong-Teck and Yun, Taesik and Kim, Hakhyun},
title = {Retrospective evaluation of risk factors for worsening renal function after angiotensin-converting enzyme inhibitor treatment in dogs},
journal = {Journal of Veterinary Internal Medicine},
year = {2025},
doi = {10.1111/jvim.17252}
}
EUVIMED